1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,064 | 0,106 | 23.06. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.06. | hVIVO PLC - Holding(s) in Company | - | RNS | ||
| 01.06. | hVIVO schließt Beratungsvertrag mit Decoy Therapeutics | 2 | Investing.com Deutsch | ||
| 01.06. | hVIVO PLC - Consultancy contract with Decoy Therapeutics | - | RNS | ||
| HVIVO Aktie jetzt für 0€ handeln | |||||
| 29.05. | hVIVO PLC - Grant of awards under Long Term Incentive Plan | - | RNS | ||
| 20.05. | hVIVO PLC - Capital Markets Day | - | RNS | ||
| 13.05. | hVIVO PLC - Result of AGM | 1 | RNS | ||
| 12.05. | hVIVO PLC - Holding(s) in Company | - | RNS | ||
| 07.05. | EARNINGS AND TRADING: MHA expects profit beat; hVIVO wins work | 1 | Alliance News | ||
| 07.05. | hVIVO signs £6m influenza clinical trial deal | 1 | Sharecast | ||
| 07.05. | hVIVO PLC - £6m Influenza HCT contract signed | - | RNS | ||
| 24.04. | hVIVO PLC - Director/PDMR Shareholding | - | RNS | ||
| 22.04. | hVIVO secures large whooping cough vaccine test contract | 1 | Sharecast | ||
| 22.04. | hVIVO PLC - HCT contract signed with ILiAD Biotechnologies | - | RNS | ||
| 17.04. | hVIVO PLC - Annual Report & Notice of AGM | 1 | RNS | ||
| 15.04. | EARNINGS AND TRADING: hVIVO swings to pretax loss after expansion | 1 | Alliance News | ||
| 15.04. | hVIVO PLC - Final Results 2025 | - | RNS | ||
| 14.04. | hVIVO PLC - hVIVO launches unified brand identity | - | RNS | ||
| 14.04. | hVIVO PLC - Influenza HCT contract signed with Traws Pharma | 1 | RNS | ||
| 07.04. | hVIVO PLC - Notice of Results | - | RNS | ||
| 26.03. | hVIVO PLC - Holding(s) in Company | 1 | RNS |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NUGEN MEDICAL DEVICES | 0,013 | -5,71 % | NuGen Medical Devices Inc.: NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance | Toronto, Ontario--(Newsfile Corp. - May 28, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle free drug delivery, today announced the filing of a new... ► Artikel lesen | |
| PLUS THERAPEUTICS | 3,620 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics to Provide Business Update Call on June 30, 2026 | ||
| UNIDOC HEALTH | 0,057 | -8,04 % | UniDoc Health Corp.: UniDoc Connect Surpasses One Million Patient Visits | Company Records 250,000 Patient Visits in First Six Months Since AMD Purchase, Then Triples to 750,000 in the Following Six Months VANCOUVER, BC / ACCESS Newswire / June 9, 2026 / UniDoc Health Corp.... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,050 | +4,17 % | Mountain Valley MD Holdings Inc: Mountain Valley MD appoints advisers, grants options | ||
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| JD HEALTH INTERNATIONAL | 3,568 | -7,56 % | JD HEALTH (06618): NEXT DAY DISCLOSURE RETURN | ||
| MEDIVOLVE | - | - | Medivolve Inc (2): OSC cites Bharti, Said for disclosure failures | ||
| LIFEWARD | 7,150 | +1,20 % | Lifeward Ltd.: Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform | Veteran physician- medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience- mobility technologies, and metabolic disease... ► Artikel lesen | |
| LIGHT AI | 0,159 | -9,69 % | Light AI Inc: Light holder MV Capital acquires 5,000 debenture units | ||
| IMUNON | 1,620 | 0,00 % | Imunon, Inc.: IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification | On track for enrollment of 80 participants by Q1 2027 Trial is supported by Phase 2 results showing significant improvement in overall survival in women with newly diagnosed advanced ovarian cancer... ► Artikel lesen | |
| ROCKWELL MEDICAL | 0,600 | +1,69 % | ROCKWELL MEDICAL, INC. - 8-K, Current Report | ||
| IMAGIN MEDICAL | - | - | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 15.05.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 15.05.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 15.05.2026.ISIN NameCA2985962067 EUREKA... ► Artikel lesen | |
| VIRIDIAN THERAPEUTICS | 15,300 | -0,65 % | XFRA 1S1: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| AROVELLA THERAPEUTICS | 0,042 | -2,33 % | AROVELLA THERAPEUTICS LIMITED: Change of Director's Interest Notice | ||
| MEMPHASYS | 0,002 | 0,00 % | XFRA IG7: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |
Das Unternehmen HVIVO PLC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,097 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HVIVO PLC finden Sie auf Wallstreet Online.